Aegate

Aegate was a specialist healthcare technology company focused on medicine authentication and patient safety. The company developed a sophisticated real-time system designed to identify falsified, recalled, or expired medicines at the point of dispensing in pharmacies. Its core service was built to ensure compliance with the European Falsified Medicines Directive (FMD) by providing a secure link between the pharmaceutical supply chain and the pharmacist. At its peak, Aegate operated across multiple European markets, processing millions of transactions to verify drug authenticity. However, the company entered administration in 2017 following the loss of several key national contract bids for the European Medicines Verification System.